|
|
 |
|
Viewing report
|
|
|
|
Avian Influenza
TriMark Publications, Aug 2006, Pages: 139
The purpose of this report is to describe the threatening world pandemic caused by avian influenza, also known as bird flu. This report discusses the origins of the disease, the bird-to-human infection risks, the catastrophic health crisis avian flu poses, and the efforts by world governments and international health organizations to mitigate of the impact the threat to humans.
The U.S., Asia and Europe are the focus of this study. Primary attention is paid to the clinical market segment and, separately, to the medical procedures and supplies for the influenza infection control market. An analysis of the technology trends and developing areas of influenza infection science is provided, along with a review of the market for pharmaceutical agents, vaccines and hospital supplies in clinical use. Activity in research-including the factors that influence infection control-are addressed in this review. Also discussed are changes that have stimulated this disease and patterns of information processing in assessing its spread. Several subjects related to the major elements of influenza treatment such as disposable plastic supplies, needles and lancets are discussed only briefly because they are considered entirely different fields or markets.
The goal of this report is to review the potential threat of a human influenza pandemic resulting from the avian flu virus. It defines the responses that are now being undertaken worldwide by governmental authorities to contain the spreading bird flu.
Specifically, this study contains:
- A comprehensive overview of the several categories of anti-influenza technology platforms that are or will be revolutionizing flu related healthcare in hospitals.
- Full descriptions of the public health measures involved in controlling the spread of avian influenza and the prevention of cross infection to humans.
- Analysis of the technological approaches undertaken by various world governments, as well as industry and end-user response to these ideas.
- Regulatory issues and legislation affecting use and marketing of influenza prevention and treatment products.
- Forecasts for each category of infection control.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector
Building a Robust Emergency Programme for Pandemics In Financial Services Lessons from SARS (2003) and Avian Flu Outbreak (2006
Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu
Is There Commercial Opportunity in the Development of a New Influenza Vaccine?
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
Antiviral Therapeutics - Technologies, Markets and Companies
Business Survival and the Influenza Pandemic: Essential Preparations For Critical Infrastructure & Businesses
Infections Influenza
General Health Issues Report: The Alliance Looks at Influenza, Obesity and Statins
U.S. Influenza Pharmaceutical Markets
The 2007-2012 Outlook for Influenza Vaccines in India
Influenza VLP Vaccine Phase II trial Conference Call - Novavax, Inc., - Earnings Transcript
|
|
|
|
